Selected data models

You must log in to select data models for download or further analysis.

60 Search results.
Relevance Rating New first Old first

Eligibility Diffuse Large B Cell Lymphoma NCT00333008

- 3/16/17 - 1 form, 2 itemgroups, 15 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
A Dose Study of Doxil in a Dose Dense, 14 Day CDOP/Rituximab Regimen for Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma (NHL)> 60 Years or With Compromised Cardiac Status.; ODM derived from: https://clinicaltrials.gov/show/NCT00333008

Eligibility Untreated CD20-Positive Large B-Cell Lymphoma NCT00169143

- 1/4/17 - 1 form, 2 itemgroups, 18 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Study of R-ACVBP Regimen Supported by Pegfilgrastim in High-Risk Diffuse Large B-Cell Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00169143

Eligibility Diffuse Large Cell Lymphoma NCT00144755

- 9/7/16 - 1 form, 2 itemgroups, 11 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
R-CHOP-14 Versus R-CHOP-21 and Darbepoetin Alpha in Patients Aged 60-80 Years With Diffuse Large B-cell Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00144755

Eligibility Diffuse Large Cell Lymphoma NCT00140660

- 9/7/16 - 1 form, 2 itemgroups, 18 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
ACVBP Versus ACVBP Plus Rituximab in Low Risk Localized Diffuse Large B-cell Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00140660

Eligibility Refractory Diffuse Large B Cell Lymphoma NCT02348216

- 6/19/16 - 1 form, 1 itemgroup, 30 items, 1 language
Itemgroup: Criteria
A Phase 1-2 Multi-Center Study Evaluating KTE-C19 in Subjects With Refractory Aggressive Non-Hodgkin Lymphoma (NHL); ODM derived from: https://clinicaltrials.gov/show/NCT02348216

Eligibility Lymphoma, Large-Cell, Diffuse NCT00135499

- 6/15/16 - 1 form, 2 itemgroups, 18 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
R-ACVBP Versus R-CHOP in Patients Aged 60-65 With Diffuse Large B-Cell Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00135499

Eligibility Lymphoma, Large-Cell, Diffuse NCT00169130

- 4/17/16 - 1 form, 2 itemgroups, 18 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
ACVBP Followed by ASCT in Patients With BCL-2 Positive Diffuse Large B-Cell Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00169130

Eligibility CD20-Positive Large B-Cell Lymphoma NCT00169169

- 3/20/16 - 1 form, 2 itemgroups, 17 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Efficacy Study of Rituximab After ASCT in High-Risk Diffuse Large B-Cell Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00169169

Eligibility Lymphoma, AIDS-related NCT00006436

- 1/23/16 - 1 form, 2 itemgroups, 23 items, 1 language
Itemgroups: Criteria, Exclusion Criteria
EPOCH and Rituximab to Treat Non-Hodgkin's Lymphoma in Patients With HIV Infection; ODM derived from: https://clinicaltrials.gov/show/NCT00006436

AMC-075B Enrollment Form (ENR) NCT01193842

- 6/3/15 - 1 form, 6 itemgroups, 14 items, 1 language
Itemgroups: Header Module, Inclusion Criteria, Exclusion Criteria, Enrollment Stratification Data, Consent For The Use Of Future Tissue Specimens, Comments
AMC-075B Enrollment Form (ENR)NCT01193842 Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With Previously Untreated HIV-Related Diffuse Large B-Cell Non-Hodgkin Lymphoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=9B26D8A0-BAA8-E8FB-E040-BB89AD4335F8

AMC-075Z Enrollment Form (ENR) NCT01193842

- 6/3/15 - 1 form, 6 itemgroups, 14 items, 1 language
Itemgroups: Header Module, Inclusion Criteria, Exclusion Criteria, Enrollment Stratification Data, Consent For The Use Of Future Tissue Specimens, Comments
AMC-075Z Enrollment Form (ENR) NCT01193842 Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With Previously Untreated HIV-Related Diffuse Large B-Cell Non-Hodgkin Lymphoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=9B26D8A0-BB1E-E8FB-E040-BB89AD4335F8

Eligibility NCT00486759 Lymphoma, B-Cell - Eligibility

- 4/14/14 - 1 form, 2 itemgroups, 7 items, 2 languages
Itemgroups: Inclusion Criteria, Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT00486759

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial